SAB Biotherapeutics Total Assets

SAB Biotherapeutics (SABS) currently reports a total assets of $250M as of March 2026. That compares with $38M in the prior-year period — up 551.8% year over year. Use the charts on this page to explore SAB Biotherapeutics's total assets history and peer comparisons.

SAB Biotherapeutics's total assets increased from $38M to $250M — a 551.8% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

SAB Biotherapeutics reported $250M in total assets as of March 2026. That compares with $38M in the prior-year period — up 551.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $250M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SAB Biotherapeutics, and consider following SABS for alerts when major investors trade the stock.